Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Notes Payables (2021 - 2023)

Historic Notes Payables for Pulse Biosciences (PLSE) over the last 3 years, with Q1 2023 value amounting to $801000.0.

  • Pulse Biosciences' Notes Payables changed N/A to $801000.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $801000.0, marking a year-over-year change of. This contributed to the annual value of $917000.0 for FY2022, which is 11032.11% up from last year.
  • According to the latest figures from Q1 2023, Pulse Biosciences' Notes Payables is $801000.0.
  • In the past 5 years, Pulse Biosciences' Notes Payables ranged from a high of $1.7 million in Q2 2021 and a low of $98000.0 during Q3 2022
  • For the 3-year period, Pulse Biosciences' Notes Payables averaged around $740857.1, with its median value being $801000.0 (2023).
  • Within the past 5 years, the most significant YoY rise in Pulse Biosciences' Notes Payables was 11032.11% (2022), while the steepest drop was 9097.61% (2022).
  • Pulse Biosciences' Notes Payables (Quarter) stood at $436000.0 in 2021, then skyrocketed by 110.32% to $917000.0 in 2022, then decreased by 12.65% to $801000.0 in 2023.
  • Its last three reported values are $801000.0 in Q1 2023, $917000.0 for Q4 2022, and $98000.0 during Q3 2022.